# Franklin Street Properties Corp: financial statements, quarterly

FSP · NYSE · CIK 1031316 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fsp.md) · [Financials](/companies/fsp/financials.md) · [Filings](/companies/fsp/filings.md) · [Insiders](/companies/fsp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fsp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [36.3](/filings/0001558370-24-010384.md) | [36.9](/filings/0001558370-24-013847.md) | [34.8 d](/filings/0001104659-26-025284.md) | [31.2](/filings/0001558370-25-005859.md) | [30.8](/filings/0001558370-25-009745.md) | [29.7](/filings/0001104659-25-103202.md) | [28.4 d](/filings/0001104659-26-025284.md) | [27.1](/filings/0001104659-26-050395.md) | [26.7](/filings/0001558370-25-009745.md) | [27.3](/filings/0001104659-25-103202.md) | [26.0 d](/filings/0001104659-26-025284.md) | [26.2](/filings/0001104659-26-050395.md) |
| Cost of revenue | $m | [12.1](/filings/0001558370-24-010384.md) | [12.8](/filings/0001558370-24-013847.md) | [13.1 d](/filings/0001104659-26-025284.md) | [11.0](/filings/0001558370-25-005859.md) | [11.0](/filings/0001558370-25-009745.md) | [11.6](/filings/0001104659-25-103202.md) | [11.4 d](/filings/0001104659-26-025284.md) | [10.1](/filings/0001104659-26-050395.md) | [10.7](/filings/0001558370-25-009745.md) | [10.7](/filings/0001104659-25-103202.md) | [10.6 d](/filings/0001104659-26-025284.md) | [10.3](/filings/0001104659-26-050395.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [6.1](/filings/0001558370-23-012761.md) | [6.2](/filings/0001558370-23-018014.md) | [6.2 d](/filings/0001558370-24-001708.md) | [6.8](/filings/0001558370-24-006276.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001558370-24-010384.md) | [0.1](/filings/0001558370-24-013847.md) | [0.1 d](/filings/0001104659-26-025284.md) | [0.1](/filings/0001558370-25-005859.md) | [0.0](/filings/0001558370-25-009745.md) | [0.1](/filings/0001104659-25-103202.md) | [0.1 d](/filings/0001104659-26-025284.md) | [0.1](/filings/0001104659-26-050395.md) | [0.1](/filings/0001558370-25-009745.md) | [0.0](/filings/0001104659-25-103202.md) | [0.1 d](/filings/0001104659-26-025284.md) | [0.1](/filings/0001104659-26-050395.md) |
| Net income | $m | [(8.4)](/filings/0001558370-24-010384.md) | [(45.7)](/filings/0001558370-24-013847.md) | [3.6 d](/filings/0001104659-26-025284.md) | [(7.6)](/filings/0001558370-25-005859.md) | [(21.0)](/filings/0001558370-25-009745.md) | [(15.6)](/filings/0001104659-25-103202.md) | [(8.5) d](/filings/0001104659-26-025284.md) | [(21.4)](/filings/0001104659-26-050395.md) | [(7.9)](/filings/0001558370-25-009745.md) | [(8.3)](/filings/0001104659-25-103202.md) | [(7.3) d](/filings/0001104659-26-025284.md) | [(9.5)](/filings/0001104659-26-050395.md) |
| Diluted EPS | $ per share | [(0.08)](/filings/0001558370-24-010384.md) | [(0.44)](/filings/0001558370-24-013847.md) | not reported | [(0.07)](/filings/0001558370-25-005859.md) | [(0.20)](/filings/0001558370-25-009745.md) | [(0.15)](/filings/0001104659-25-103202.md) | not reported | [(0.21)](/filings/0001104659-26-050395.md) | [(0.08)](/filings/0001558370-25-009745.md) | [(0.08)](/filings/0001104659-25-103202.md) | not reported | [(0.09)](/filings/0001104659-26-050395.md) |
| Basic EPS | $ per share | [(0.08)](/filings/0001558370-24-010384.md) | [(0.44)](/filings/0001558370-24-013847.md) | not reported | [(0.07)](/filings/0001558370-25-005859.md) | [(0.20)](/filings/0001558370-25-009745.md) | [(0.15)](/filings/0001104659-25-103202.md) | not reported | [(0.21)](/filings/0001104659-26-050395.md) | [(0.08)](/filings/0001558370-25-009745.md) | [(0.08)](/filings/0001104659-25-103202.md) | not reported | [(0.09)](/filings/0001104659-26-050395.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: not reported
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.9](/filings/0001558370-24-010384.md) | [13.0](/filings/0001558370-24-013847.md) | [126](/filings/0001558370-25-000806.md) | [34.2](/filings/0001558370-25-005859.md) | [30.2](/filings/0001558370-25-009745.md) | [40.9](/filings/0001104659-25-103202.md) | [41.1](/filings/0001104659-26-025284.md) | [30.2](/filings/0001104659-26-050395.md) | [29.4](/filings/0001558370-25-009745.md) | [31.4](/filings/0001104659-25-103202.md) | [30.6](/filings/0001104659-26-025284.md) | [23.8](/filings/0001104659-26-050395.md) |
| Total assets | $m | [1,199](/filings/0001558370-23-012761.md) | [1,152](/filings/0001558370-23-018014.md) | [1,169](/filings/0001558370-25-000806.md) | [1,039](/filings/0001558370-24-006276.md) | [1,013](/filings/0001558370-24-010384.md) | [982](/filings/0001558370-24-013847.md) | [947](/filings/0001104659-26-025284.md) | [916](/filings/0001558370-25-005859.md) | [903](/filings/0001558370-25-009745.md) | [901](/filings/0001104659-25-103202.md) | [893](/filings/0001104659-26-050395.md) | [882](/filings/0001104659-26-050395.md) |
| Total liabilities | $m | [440](/filings/0001558370-23-012761.md) | [440](/filings/0001558370-23-018014.md) | [457](/filings/0001558370-25-000806.md) | [335](/filings/0001558370-24-006276.md) | [330](/filings/0001558370-24-010384.md) | [316](/filings/0001558370-24-013847.md) | [291](/filings/0001104659-26-025284.md) | [283](/filings/0001558370-25-005859.md) | [279](/filings/0001558370-25-009745.md) | [286](/filings/0001104659-25-103202.md) | [286](/filings/0001104659-26-050395.md) | [285](/filings/0001104659-26-050395.md) |
| Shareholders' equity | $m | [759](/filings/0001558370-24-013847.md) | [711](/filings/0001558370-24-013847.md) | [713](/filings/0001104659-26-025284.md) | [704](/filings/0001104659-25-103202.md) | [682](/filings/0001104659-25-103202.md) | [665](/filings/0001104659-25-103202.md) | [656](/filings/0001104659-26-050395.md) | [633](/filings/0001104659-26-050395.md) | [625](/filings/0001104659-25-103202.md) | [615](/filings/0001104659-25-103202.md) | [607](/filings/0001104659-26-050395.md) | [596](/filings/0001104659-26-050395.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.6 d](/filings/0001558370-24-010384.md) | [11.1 d](/filings/0001558370-24-013847.md) | [6.3 d](/filings/0001104659-26-025284.md) | [(7.1)](/filings/0001558370-25-005859.md) | [(0.6) d](/filings/0001558370-25-009745.md) | [14.5 d](/filings/0001104659-25-103202.md) | [2.3 d](/filings/0001104659-26-025284.md) | [(5.5)](/filings/0001104659-26-050395.md) | [(2.9) d](/filings/0001558370-25-009745.md) | [8.3 d](/filings/0001104659-25-103202.md) | [3.8 d](/filings/0001104659-26-025284.md) | [(5.2)](/filings/0001104659-26-050395.md) |
| Capital expenditure | $m | [6.9 d](/filings/0001558370-24-010384.md) | [7.7 d](/filings/0001558370-24-013847.md) | [5.6 d](/filings/0001104659-26-025284.md) | [8.8](/filings/0001558370-25-005859.md) | [4.5 d](/filings/0001558370-25-009745.md) | [5.8 d](/filings/0001104659-25-103202.md) | [6.1 d](/filings/0001104659-26-025284.md) | [4.5](/filings/0001104659-26-050395.md) | [2.9 d](/filings/0001558370-25-009745.md) | [5.3 d](/filings/0001104659-25-103202.md) | [3.8 d](/filings/0001104659-26-025284.md) | [2.7](/filings/0001104659-26-050395.md) |
| Dividends paid | $m | [1.0 d](/filings/0001558370-24-010384.md) | [1.0 d](/filings/0001558370-24-013847.md) | [1.0 d](/filings/0001104659-26-025284.md) | [1.0](/filings/0001558370-25-005859.md) | [1.0 d](/filings/0001558370-25-009745.md) | [1.0 d](/filings/0001104659-25-103202.md) | [1.0 d](/filings/0001104659-26-025284.md) | [1.0](/filings/0001104659-26-050395.md) | [1.0 d](/filings/0001558370-25-009745.md) | [1.0 d](/filings/0001104659-25-103202.md) | [1.0 d](/filings/0001104659-26-025284.md) | [1.0](/filings/0001104659-26-050395.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [103](/filings/0001558370-23-012761.md) | [103](/filings/0001558370-23-018014.md) | [103](/filings/0001558370-24-006276.md) | [103](/filings/0001558370-24-010384.md) | [103](/filings/0001558370-24-013847.md) | [103](/filings/0001558370-25-005859.md) | [103](/filings/0001558370-25-009745.md) | [104](/filings/0001104659-25-103202.md) | [104](/filings/0001104659-26-050395.md) | [104](/filings/0001558370-25-009745.md) | [104](/filings/0001104659-25-103202.md) | [104](/filings/0001104659-26-050395.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 103,690,340 at 2026-04-23, from the cover of the [10-Q filed 2026-04-28](/filings/0001104659-26-050395.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.